240
Views
4
CrossRef citations to date
0
Altmetric
Letter to the Editor

Response of plasmacytomas to low-dose thalidomide in a patient with refractory multiple myeloma

Pages 215-216 | Received 03 Oct 2003, Accepted 22 Oct 2003, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ramón García-Sanz. (2006) Thalidomide in multiple myeloma. Expert Opinion on Pharmacotherapy 7:2, pages 195-213.
Read now

Articles from other publishers (3)

Yasunobu Sekiguchi, Taito Asahina, Asami Shimada, Hidenori Imai, Mutsumi Wakabayashi, Keiji Sugimoto, Noriko Nakamura, Tomonori Sawada, Norio Komatsu & Masaaki Noguchi. (2013) A Case of Extramedullary Plasmablastic Plasmacytoma Successfully Treated Using a Combination of Thalidomide and Dexamethasone and a Review of the Medical Literature. Journal of Clinical and Experimental Hematopathology 53:1, pages 21-28.
Crossref
Hajime Yasuda, Jun Ando, Eriko Sato, Naoko Inagaki, Nanae Aritaka, Norio Komatsu & Takao Hirano. (2010) Successful Treatment of Extramedullary Tumors with Low-dose Thalidomide in Patients with Multiple Myeloma. Internal Medicine 49:23, pages 2617-2620.
Crossref
K L Wu, H H Helgason, B van der Holt, P W Wijermans, H M Lokhorst, W M Smit & P Sonneveld. (2004) Analysis of efficacy and toxicity of thalidomide in 122 patients with multiple myeloma: response of soft-tissue plasmacytomas. Leukemia 19:1, pages 143-145.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.